|
시장보고서
상품코드
2049788
족하수 임플란트 시장 보고서 : 제품별, 최종사용자별, 지역별(2026-2034년)Foot Drop Implants Market Report by Product (Functional Electrical Stimulators, Internal Fixation Devices), End User (Hospitals, Palliative Care Centers, Orthopedic Centers, and Others), and Region 2026-2034 |
||||||
세계의 족하수 임플란트 시장 규모는 2025년에 45억 달러에 달했습니다. 향후 IMARC Group은 2026년부터 2034년까지 CAGR 5.89%를 기록하며 2034년까지 시장 규모가 77억 달러에 달할 것으로 예측하고 있습니다. 발목 처짐 및 신경 질환의 유병률 증가, 고령 인구 증가, 맞춤형 치료 솔루션에 대한 수요 증가, 임플란트 설계 및 재료의 기술적 진보가 시장을 이끄는 주요 요인 중 일부입니다.
족하수는 앞발이 처지거나 발 앞부분을 들어올리기 힘들어지는 것이 특징인 신경질환을 말합니다. 보통 총비골신경의 손상, 발목과 다리의 움직임을 조절하는 근육의 근력저하나 마비, 또는 뇌졸중, 다발성 경화증, 뇌성마비 등의 외상이나 질병으로 인해 발생합니다. 이로 인해 정상적인 보행이 어려워지거나 보행이 흐트러질 수 있으며, 걸음걸이, 등 굽힘 등의 증상을 동반하는 것이 일반적입니다. 족하수 임플란트는 손상된 부위를 대체하거나 보강하여 이 질환으로 인한 기능적 제한을 완화하기 위해 고안된 의료기기입니다. 발목과 발에 안정성과 지지력을 제공하여 환자가 일상생활을 쉽게 할 수 있도록 이동성을 회복하고 삶의 질을 향상시켜 줍니다. 그 결과, 족하수 임플란트는 기능 회복과 환자의 자연스러운 보행 촉진으로 의료계 전반에 걸쳐 큰 인기를 끌고 있습니다.
족하수 임플란트 시장 동향:
신경 손상, 스포츠 부상, 교통사고 증가에 따른 족하수의 유병률 증가는 시장 성장을 뒷받침하는 주요 요인 중 하나입니다. 또한, 이 증상에 걸리기 쉬운 고령 인구의 증가로 인해 전 세계적으로 족저근막하출혈 임플란트에 대한 수요가 증가하고 있습니다. 또한, 회복 기간이 짧고, 흉터와 절개 부위가 적으며, 합병증 위험도 줄일 수 있어 하지정맥류 치료에서 최소침습(MI) 수술로의 전환이 눈에 띄게 진행되고 있습니다. 이에 따라 직접적인 기계적 지지력을 제공하고 근육 기능을 회복시키기 위한 수술용 족하수 임플란트의 사용 확대가 제품 채택률을 가속화하고 있습니다. 또한, 주요 제조업체들은 더 나은 안정성, 지지력, 편안함 및 사용 편의성을 제공하는 새로운 임플란트 변형 제품 출시에 주력하고 있습니다. 이러한 제품 혁신은 환자의 치료 결과와 만족도를 향상시켜 시장 성장을 견인하고 있습니다. 이와 더불어, 유리한 상환 정책을 쉽게 이용할 수 있다는 점과 개인화된 치료 옵션에 대한 수요 증가가 시장 성장을 촉진하고 있습니다. 그 외 신경질환 발생률 증가, 의료 인프라 개선, 의료비 증가, 임플란트 설계 및 재료의 기술적 진보, 지속적인 연구개발(R&D) 활동 등의 요인도 향후 몇 년 동안 시장 성장을 촉진할 것으로 예상됩니다.
본 보고서에서 답변하는 주요 질문
- 지금까지의 세계 족하수 임플란트 시장 동향은 어떠했으며, 향후 몇 년 동안 어떻게 변화할 것인가?
- 세계 족하수 임플란트 시장의 촉진요인, 억제요인 및 기회는 무엇인가?
- 각 촉진요인, 제약요인 및 기회는 세계 족하수 임플란트 시장에 어떤 영향을 미치는가?
- 주요 지역 시장은 어디인가?
- 어떤 국가가 가장 매력적인 족하수 임플란트 시장을 형성하고 있는가?
- 제품별로 보면 시장 분석은 어떻게 이루어지는가?
- 족하수 임플란트 시장에서 가장 매력적인 제품은 무엇인가?
- 최종사용자별 시장 분석은 어떻게 이루어지고 있는가?
- 족하수 임플란트 시장에서 가장 매력적인 최종사용자는 누구인가?
- 세계 족하수 임플란트 시장의 경쟁 구조는 어떠한가?
- 세계 족하수 임플란트 시장의 주요 플레이어/기업은 어디인가?
목차
제1장 서문
제2장 조사 범위와 조사 방법
제3장 주요 요약
제4장 소개
제5장 세계의 족하수 임플란트 시장
제6장 시장 내역 : 제품별
제7장 시장 내역 : 최종사용자별
제8장 시장 내역 : 지역별
제9장 촉진요인, 억제요인, 기회
제10장 밸류체인 분석
제11장 Porter's Five Forces 분석
제12장 가격 분석
제13장 경쟁 구도
KSM 26.06.10The global foot drop implants market size reached USD 4.5 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 7.7 Billion by 2034, exhibiting a growth rate (CAGR) of 5.89% during 2026-2034. The rising prevalence of foot drop and neurological disorders, expanding geriatric population, escalating demand for personalized treatment solutions, and technological advancements in implant design and materials represent some of the key factors driving the market.
Foot drop refers to a neurological disorder characterized by the dropping of the forefoot or difficulty in lifting the front part of the foot. It usually occurs due to damage to the common fibular nerve, weakness or paralysis of the muscles that control the ankle and foot movement, or injuries and conditions such as stroke, multiple sclerosis, and cerebral palsy. It can lead to difficulty or deviation from normal walking and is commonly associated with symptoms such as steppage gait and dorsiflexion. Foot drop implants are medical devices designed to reduce the functional limitations caused by this condition by replacing or reinforcing the damaged part. They provide stability and support to the ankle and foot, allowing patients to regain mobility and perform daily activities easily while improving the quality of their lives. As a result, food drop implants are gaining immense popularity across the healthcare industry for restoring function and facilitating a more natural gait in patients.
FOOT DROP IMPLANTS MARKET TRENDS:
The rising prevalence of foot drop owing to the increasing cases of nerve damage, sports-related injuries, and road accidents represents one of the primary factors supporting the market growth. Moreover, the expanding geriatric population that is more susceptible to developing this condition is leading to a higher demand for foot drop implants across the globe. Additionally, there has been a significant shift toward minimally invasive (MI) surgical procedures for foot drop treatment as they offer a shorter recovery period, less scarring and incision, and reduced risk of complications. In line with this, the growing utilization of surgical foot drop implants to provide direct mechanical support and restore muscle function has accelerated product adoption rates. Furthermore, the leading manufacturers are focusing on the launch of novel implant variants that offer better stability, support, comfort, and ease of use. Such product innovations are improving patient outcomes and satisfaction, thereby propelling market growth. Besides this, the easy availability of favorable reimbursement policies and the escalating demand for personalized treatment options are augmenting market growth. Other factors, including the rising incidences of neurological disorders, improving medical infrastructure, increasing healthcare expenditure, technological advancements in implant design and materials, and ongoing research and development (R&D) activities, are also anticipated to fuel market growth in the coming years.
KEY MARKET SEGMENTATION:
Product Insights:
- Functional Electrical Stimulators
- Internal Fixation Devices
End User Insights:
- Hospitals
- Palliative Care Centers
- Orthopedic Centers
- Others
Regional Insights:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for foot drop implants. Some of the factors driving the North America foot drop implants market included the growing burden of neurological conditions, rapidly aging population, continuous technological advancements and product launches by key players, etc.
COMPETITIVE LANDSCAPE:
The report has also provided a comprehensive analysis of the competitive landscape in the global foot drop implants market. Detailed profiles of all major companies have been provided. Some of the companies covered include aap Implantate AG, Acumed LLC (Colson Medical LLC), Arthrex Inc., Bioness Inc. (Bioventus Inc.), Narang Medical Limited, Ottobock SE & Co. KGaA, Stryker Corporation, Zimmer Biomet, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
KEY QUESTIONS ANSWERED IN THIS REPORT
- How has the global foot drop implants market performed so far, and how will it perform in the coming years?
- What are the drivers, restraints, and opportunities in the global foot drop implants market?
- What is the impact of each driver, restraint, and opportunity on the global foot drop implants market?
- What are the key regional markets?
- Which countries represent the most attractive foot drop implants market?
- What is the breakup of the market based on the product?
- Which is the most attractive product in the foot drop implants market?
- What is the breakup of the market based on the end user?
- Which is the most attractive end user in the foot drop implants market?
- What is the competitive structure of the global foot drop implants market?
- Who are the key players/companies in the global foot drop implants market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Foot Drop Implants Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product
- 6.1 Functional Electrical Stimulators
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Internal Fixation Devices
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
7 Market Breakup by End User
- 7.1 Hospitals
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Palliative Care Centers
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Orthopedic Centers
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Others
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
8 Market Breakup by Region
- 8.1 North America
- 8.1.1 United States
- 8.1.1.1 Market Trends
- 8.1.1.2 Market Forecast
- 8.1.2 Canada
- 8.1.2.1 Market Trends
- 8.1.2.2 Market Forecast
- 8.1.1 United States
- 8.2 Asia-Pacific
- 8.2.1 China
- 8.2.1.1 Market Trends
- 8.2.1.2 Market Forecast
- 8.2.2 Japan
- 8.2.2.1 Market Trends
- 8.2.2.2 Market Forecast
- 8.2.3 India
- 8.2.3.1 Market Trends
- 8.2.3.2 Market Forecast
- 8.2.4 South Korea
- 8.2.4.1 Market Trends
- 8.2.4.2 Market Forecast
- 8.2.5 Australia
- 8.2.5.1 Market Trends
- 8.2.5.2 Market Forecast
- 8.2.6 Indonesia
- 8.2.6.1 Market Trends
- 8.2.6.2 Market Forecast
- 8.2.7 Others
- 8.2.7.1 Market Trends
- 8.2.7.2 Market Forecast
- 8.2.1 China
- 8.3 Europe
- 8.3.1 Germany
- 8.3.1.1 Market Trends
- 8.3.1.2 Market Forecast
- 8.3.2 France
- 8.3.2.1 Market Trends
- 8.3.2.2 Market Forecast
- 8.3.3 United Kingdom
- 8.3.3.1 Market Trends
- 8.3.3.2 Market Forecast
- 8.3.4 Italy
- 8.3.4.1 Market Trends
- 8.3.4.2 Market Forecast
- 8.3.5 Spain
- 8.3.5.1 Market Trends
- 8.3.5.2 Market Forecast
- 8.3.6 Russia
- 8.3.6.1 Market Trends
- 8.3.6.2 Market Forecast
- 8.3.7 Others
- 8.3.7.1 Market Trends
- 8.3.7.2 Market Forecast
- 8.3.1 Germany
- 8.4 Latin America
- 8.4.1 Brazil
- 8.4.1.1 Market Trends
- 8.4.1.2 Market Forecast
- 8.4.2 Mexico
- 8.4.2.1 Market Trends
- 8.4.2.2 Market Forecast
- 8.4.3 Others
- 8.4.3.1 Market Trends
- 8.4.3.2 Market Forecast
- 8.4.1 Brazil
- 8.5 Middle East and Africa
- 8.5.1 Market Trends
- 8.5.2 Market Breakup by Country
- 8.5.3 Market Forecast
9 Drivers, Restraints, and Opportunities
- 9.1 Overview
- 9.2 Drivers
- 9.3 Restraints
- 9.4 Opportunities
10 Value Chain Analysis
11 Porters Five Forces Analysis
- 11.1 Overview
- 11.2 Bargaining Power of Buyers
- 11.3 Bargaining Power of Suppliers
- 11.4 Degree of Competition
- 11.5 Threat of New Entrants
- 11.6 Threat of Substitutes
12 Price Analysis
13 Competitive Landscape
- 13.1 Market Structure
- 13.2 Key Players
- 13.3 Profiles of Key Players
- 13.3.1 aap Implantate AG
- 13.3.1.1 Company Overview
- 13.3.1.2 Product Portfolio
- 13.3.1.3 Financials
- 13.3.2 Acumed LLC (Colson Medical LLC)
- 13.3.2.1 Company Overview
- 13.3.2.2 Product Portfolio
- 13.3.3 Arthrex Inc.
- 13.3.3.1 Company Overview
- 13.3.3.2 Product Portfolio
- 13.3.3.3 SWOT Analysis
- 13.3.4 Bioness Inc. (Bioventus Inc.)
- 13.3.4.1 Company Overview
- 13.3.4.2 Product Portfolio
- 13.3.5 Narang Medical Limited
- 13.3.5.1 Company Overview
- 13.3.5.2 Product Portfolio
- 13.3.6 Ottobock SE & Co. KGaA
- 13.3.6.1 Company Overview
- 13.3.6.2 Product Portfolio
- 13.3.6.3 SWOT Analysis
- 13.3.7 Stryker Corporation
- 13.3.7.1 Company Overview
- 13.3.7.2 Product Portfolio
- 13.3.7.3 Financials
- 13.3.7.4 SWOT Analysis
- 13.3.8 Zimmer Biomet
- 13.3.8.1 Company Overview
- 13.3.8.2 Product Portfolio
- 13.3.8.3 Financials
- 13.3.8.4 SWOT Analysis
- 13.3.1 aap Implantate AG
